Brief: 4D Molecular Therapeutics Q1 Net Income USD -68.76 Million Vs. IBES Estimate USD -62.6 Million
07/05/2026 21:05
May 07 (Reuters) - 4D Molecular Therapeutics Q1 operating expenses USD 76.667 million. Q1 operating income USD -73.62 million vs. IBES estimate USD -66.5 million Q1 basic EPS USD -1.01 Q1 revenue USD 3.047 million
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings